Why was the database created?
To make aggregated public health indicators relevant to their activities, calculated from SNDS data, accessible to healthcare stakeholders (patient or healthcare professional associations, small and medium-sized businesses, etc.). Secondly, to limit the number of individual SNDS data processing operations needed to build simple aggregated indicators, with a view to privacy by design.
What data does the database contain?
- Population of interest
- All the SNDS, with a historical depth of 10 years, with selection of the variables of interest. Magellan respects the principle of data minimization and is therefore supplied by less than 35% of the 240 variables transmitted by the CNAM.
- Main inclusion criteria
- All beneficiaries of reimbursement by the French national health insurance (Assurance Maladie)
- Age group
- Adolescent (12 to 18) Adult (18 to 64) Child (2 to 11) Infant (28 days to 23 months) Newborn (0 to 27 days) Older adult (65 and over)
- Data category
- Medical and administrative data
How is the data managed?
- Data retention period
- Warehouse authorized for 10 years, with 10 years of historical data and annual updates of SNDS data
- Database documentation
Why is the database legal?
- Data controller
- Clinityx
- Legal basis
- Processing of health data based on the legitimate interests of the data controller in setting up a health data warehouse enabling increased use of SNDS data Processing of health data made necessary for reasons of public interest in the field of public health
- Data quality and completion
- Comprehensive French data
- Data transfer outside the EU
- None
Data sources feeding Magellan health data warehouse
Système national des données de santé (SNDS) Data from 01/2017 to 12/2022 Le SNDS a pour finalité la mise disposition de ces données afin de favoriser les études, recherches ou évaluations présentant un caractère d’intérêt public et contribuant à l’information sur la santé, la mise en œuvre d… Read more →Research projects powered by Magellan health data warehouse
Magellan - Myasthénie Gravis
Analysis in progress
Read more →
Magellan - Diabètes et ses traitements
Completed
Read more →
Magellan étude de faisabilité
Not started
Read more →
Magellan - Vitiligo
Completed
Read more →
Magellan - Anti TNF Alpha
Follow-up in progress
Read more →
Magellan - Etude STIGMATE - Analyse des coûts de prise en charge Médicamenteuse des patients atteints d’insuffisance Tricuspide cliniquement significative en France
Completed
Read more →
Magellan - Qualité - Pipe Victoria
Not started
Read more →
Magellan - Cancer du sein avancé ou métastatique
Analysis in progress
Read more →
Magellan - La dermatite atopique (DA)
Analysis in progress
Read more →
Magellan - Vaso protecteurs
Completed
Read more →
Magellan - Appareil de neurostimulation électrique transcutanée
Analysis in progress
Read more →
Magellan - Anti TNF - Humira
Completed
Read more →
Magellan - Maladie de Verneuil
Follow-up in progress
Read more →
Magellan - Patients de Myélome multiple en France
Not started
Read more →
Magellan - Nine - Evaluation du fardeau du cancer HR+/HER2- & HER2+ en France
Recruitment in progress
Read more →
Magellan - Arthrose
Recruitment in progress
Read more →
IMIDO - Impact of Multimorbidity related risk stacking on COVID-19 related Outcomes in the hospital setting
Follow-up in progress
Read more →
Comorbidités et mortalité en France - Evaluation des scores de Charlson, d'Elixhauser, et des disparités socio-démographiques via l'EDS Magellan
Follow-up in progress
Read more →
Magellan - ALD 25 - Sclérose en plaque
Analysis in progress
Read more →
Magellan - Myocardite
Analysis in progress
Read more →
Carence Vitamine D : Usage en préventif et curatif en France via l'EDS Magellan
Recruitment in progress
Read more →
Magellan - Amylose cardiaque à TTR
Recruitment in progress
Read more →
Magellan - REPEAT - Persistance dans la vie réelle aux traitements antifibrosants
Completed
Read more →
Magellan Mesh - BSU - Implantation de bandelettes sous-urétrales
Not started
Read more →
Magellan - Obésité et surpoids
Recruitment in progress
Read more →
Magellan - Maladies rares et accès dérogatoires
Not started
Read more →
VITALE: Etude de la Variabilité Interdépartementale du Temps d'attente pour un remplacement Aortique et de L'Equité d'accès aux soins
Not started
Read more →
Magellan - Les cellules CAR T
Follow-up in progress
Read more →
Magellan - exploratoire BPCO – avec focus sur 2 populations non diagnostiqués et à risque d’exacerbation
Recruitment in progress
Read more →
Magellan - Cancer du rein (post néphrectomie) – segmentation de population à bas / haut Risque de Récidive– étude exploratoire
Recruitment in progress
Read more →
Magellan - Maladie rénale chronique (MRC) et insuffisance rénale chronique (IRC) via l'EDS Magellan
Recruitment in progress
Read more →
Télésurveillance médicale via l'EDS Magellan
Not started
Read more →
Couverture vaccinale en France via l'EDS Magellan
Not started
Read more →
Magellan - Diabète / Population sous Gliflozines
Completed
Read more →
Magellan - Oxygénothérapie à Domicile - HAD - MAD
Completed
Read more →
Magellan - Accès dérogatoire à un traitement
Analysis in progress
Read more →
Magellan - FOCUS - Leucémie myéloide chronique - L'utilisation et les résultats de survie chez les patients traités par gilteritinib
Not started
Read more →
Insuffisance Cardiaque et déploiement des inhibiteurs SGLT2 en France via l' EDS Magellan
Recruitment in progress
Read more →